Part, Chapter, Paragraph
1 II, 5. 4. 1| replacement therapy: dialysis or transplantation);~Impotence: On average,
2 II, 5. 4. 2| incidence of dialysis and/or transplantation (renal replacement therapy
3 II, 5. 4. 2| Prevalence (stock) of dialysis/transplantation (renal replacement therapy)
4 II, 5. 4. 2| incidence of dyalisis and/or transplantation is defined as the number
5 II, 5. 4. 2| cases with dialysis and/or transplantation (renal replacement therapy)
6 II, 5. 4. 2| Prevalence (stock) of dialysis/transplantation per 100.000 diabetic population
7 II, 5. 4. 2| all cases with dialysis/transplantation per 100,000 individuals
8 II, 5. 4. 3| incidence of dyalisis and/or transplantation. EUCID found a variation
9 II, 5. 4. 3| Prevalence (stock) of dialysis/transplantation per 100.000 diabetic population.
10 II, 5. 7. 1| stage where dialysis and transplantation are needed, second because
11 II, 5. 7. 1| Pontoriero et al, 2007). Renal transplantation is the most cost-effective
12 II, 5. 7. 1| imaging abnormalities~• kidney transplantation~2. GFR <60 ml/min/1.73 m2 ,
13 II, 5. 7. 1| V codes for dialysis or transplantation~5 D if dialysis (HD or PD)~ ~*
14 II, 5. 7. 3| high as that after kidney transplantation: 60% and 13%, respectively.~
15 II, 5. 7. 5| the Austrian Dialysis- and Transplantation Registry (OEDTR) shall take
16 II, 5. 7. 5| average waiting time for transplantation is about 2 years. Accessibility
17 II, 5. 7. 6| cadaver kidneys for renal transplantation is far below the demand.
18 II, 5. 12. 3| liver functions and liver transplantation – may also have had some
19 II, 5. 12. 6| the introduction of liver transplantation.~ ~The impact of the introduction
20 II, 5. 12. 6| long-term prognosis after liver transplantation and the fact that the procedure
21 II, 5. 12. 6| of cirrhosis cases, liver transplantation is performed after identification
22 II, 5. 12. 6| the favourable impact of transplantation on chronic liver disease
23 II, 5. 12. 6| wider adoption of liver transplantation in the future is likely
24 II, 5. 12. 7| Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using
25 II, 6. 3. 7| infection through organ transplantation and blood transfusion has
26 IV, 11. 5. 1| the past 50 years, organ transplantation has become established worldwide,
27 IV, 11. 5. 1| use of human organs for transplantation has steadily increased during
28 IV, 11. 5. 1| the past decades. Organ transplantation is now the most cost-effective
29 IV, 11. 5. 1| exchanges mean that the transplantation process is carried out by
30 IV, 11. 5. 1| jurisdictions. Organ donation and transplantation are sensitive and complex
31 IV, 11. 5. 1| Lithuania).~In a NTO model, transplantation is a complex healthcare
32 IV, 11. 5. 1| planning all donation and transplantation activities within their
33 IV, 11. 5. 1| favourable results of organ transplantation, by enlarging the recipient
34 IV, 11. 5. 1| initially limited to renal transplantation and later expanding to the
35 IV, 11. 5. 1| heart, lung and tissue transplantation.~ ~Figure 11.10. International
36 IV, 11. 5. 1| Figures On Organ Donation and Transplantation~ ~Success of transplantation
37 IV, 11. 5. 1| Transplantation~ ~Success of transplantation indeed depends on several
38 IV, 11. 5. 2| European Society for Organ Transplantation (ESOT) ( w ~ ~EU National
39 IV, 11. 5. 2| Registry for Heart and Lung Transplantation: htt Spanish Bone Marrow
40 IV, 11. 5. 3| European survey on donation and transplantation activities~ ~In 2003 the
41 IV, 11. 5. 3| 2003) related to organ transplantation in the 25 EU Member States
42 IV, 11. 5. 3| aspects in the field of organ transplantation. The results of this survey
43 IV, 11. 5. 3| Authorisation for transplantation procedures~ ~The requirements
44 IV, 11. 5. 3| organ procurement, organ transplantation (figure 11.12) organ exchange
45 IV, 11. 5. 3| countries~Figure 11.12. Organ transplantation in different European countries~
46 IV, 11. 5. 3| guidelines:~ ~Figure 11.18. Organ transplantation procedures.~ ~
47 IV, 11. 5. 4| face with regard to organ transplantation of humans organs by organized
48 IV, 11. 5. 4| activity and 5% of liver transplantation. Although living donors
49 IV, 11. 5. 4| always been critical for transplantation, the donations from living
50 IV, 11. 5. 4| donation.~Organ donation and transplantation are medical treatments that
51 IV, 11. 5. 4| professionals and the media about transplantation issues.~Because both positive
52 IV, 11. 5. 4| organise the donation and transplantation activities.~The different
53 IV, 11. 5. 4| differences in organ donation and transplantation activity, with some organisational
54 IV, 11. 5. 4| process from procurement to transplantation should be completed in a
55 IV, 11. 5. 4| element of organ donation/transplantation systems.~As part of this
56 IV, 11. 5. 4| process from organ donation to transplantation, whose complexity may make
57 IV, 11. 5. 4| safety of organ donation and transplantation~ ~Transmission of HIV/AIDS,
58 IV, 11. 5. 4| fungi and parasites through transplantation, as well as of for different
59 IV, 11. 5. 4| essential part of solid organ transplantation.~This evaluation must provide
60 IV, 11. 5. 5| 11.5.5. Research in the transplantation field~ ~Current situation
61 IV, 11. 5. 5| potential impact, related to transplantation medicine both in terms of
62 IV, 11. 5. 5| implement a new vision of transplantation research requiring a high
63 IV, 11. 5. 5| the project called TRIE (Transplantation Research Integration across
64 IV, 11. 5. 5| European research project in transplantation field:~ ~ETPOD is a project
65 IV, 11. 5. 5| Programmes on Organ Donation and Transplantation):~The Alliance-O consortium
66 IV, 11. 5. 5| decided to focus on organ transplantation policies and planned to
67 IV, 11. 5. 5| programmes for improving Organ Transplantation efficiency addressed in
68 IV, 11. 5. 5| safety and quality of organ transplantation, the evaluation methodology
69 IV, 11. 5. 5| the organisation of organ transplantation.~Duration: : 3 years.~-
70 IV, 11. 5. 6| research programmes on organ transplantation in order to maximise the
71 IV, 11. 5. 6| of cooperation in organ transplantation (SP-CTO). This group prepared
72 IV, 11. 5. 6| a Steering Committee on Transplantation (CD-PTO) and will continue
73 IV, 11. 5. 6| to human organ and tissue transplantation dated January 24, 2002.
74 IV, 11. 5. 6| publications in the organ transplantation field~ ~2005Recom 11 on
75 IV, 11. 5. 6| the authorisation of organ transplantation facilities~2004Recom )8
76 IV, 11. 5. 6| document~1997Recom 16 on liver transplantation from living related donors~
77 IV, 11. 5. 6| problems raised by organ transplantation~ – Organisational and educational
78 IV, 11. 5. 6| educational aspects of organ transplantation~ – Legislative measures
79 IV, 11. 5. 6| measures in relation to organ transplantation and to European co-operation~ –
80 IV, 11. 5. 6| co-operation~1987 Renal transplantation: sense and sensitization
81 IV, 11. 5. 6| to removal, grafting and transplantation of human substances~ ~·
82 IV, 11. 5. 6| organs of human origin~ ~Transplantation in general has higher measurable
83 IV, 11. 5. 6| therapies. Results of organ transplantation are progressively improving
84 IV, 11. 5. 7| donation and equalise access to transplantation. Since the potential growth
85 IV, 11. 6. 2| e.g. diabetes, epilepsy, transplantation, leprosy, syphilis, cancerous
86 IV, 11. 6. 4| disease areas (orthopaedics, transplantation, emergency, neonatal/maternal,
87 IV, 11. 6. 5| Commission (2003): Human organ~transplantation in Europe: an overview [
88 IV, 11. 6. 5| research on cell and organ transplantation: towards novel opportunities?
89 IV, 13. 7 | human origin. Today, organ transplantation has become a common and
90 IV, 13. 7. 3| cancers in infants, and heart transplantation in children), evaluation
91 Key, Ap5. 0. 0| trafficking~transfusion~transplant~transplantation~transplanted~transplants~
